江豐電子(300666.SZ)與睿昇公司簽訂合作協議 向其發出代工訂單
格隆匯12月27日丨江豐電子(300666.SZ)公佈,為了加速推動公司半導體精密零部件業務的發展,公司擬與北京睿昇精機半導體科技有限公司(簡稱“北京睿昇”)、瀋陽睿昇精密製造有限公司(簡稱“瀋陽睿昇”,與北京睿昇合稱“睿昇公司”)簽訂《寧波江豐電子材料股份有限公司與北京睿昇精機半導體科技有限公司、瀋陽睿昇精密製造有限公司的合作協議》,睿昇公司接受江豐電子的代工訂單,向江豐電子供應半導體設備零配件。此次交易構成關聯交易。
公司該次與睿昇公司簽訂合作協議,旨在與睿昇公司建立長期穩定的戰略合作關係,保障公司半導體設備零配件供應的穩定性和安全性,加速推動公司半導體精密零部件業務的發展,符合公司長期發展戰略目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.